Methylene blue, an FDA-approved medication, shows promise in treating mental disorders by enhancing mitochondrial function and increasing cellular energy, thereby supporting neuroplasticity.
The combined effects of methylene blue and photobiomodulation suggest a robust potential in improving conditions like depression, anxiety, and neurodegenerative diseases through increased energy and neuroplasticity.
Collection
[
|
...
]